Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 222

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Impact of COVID-19 restrictions on diabetes health checks and prescribing for people with type 2 diabetes: a UK-wide cohort study involving 618 161 people in primary care

Open access
Carr, Matthew J, Wright, Alison K, Leelarathna, Lalantha, Thabit, Hood, Milne, Nicola, Kanumilli, Naresh, Ashcroft, Darren M, Rutter, Martin K · 2022 · BMJ Quality & Safety

Published version of a preprint

Abstract

Objective: To compare rates of performing National Institute for Health and Care Excellence-recommended health checks and prescribing in people with type 2 diabetes (T2D), before and after the first COVID-19 peak in March 2020, and to assess whether trends varied by age, sex, ethnicity and deprivation. Methods: We studied 618 161 people with T2D followed between March and December 2020 from 1744 UK general practices registered with the Clinical Practice Research Datalink. We focused on six health checks: haemoglobin A1c, serum creatinine, cholesterol, urinary albumin excretion, blood pressure and body mass index assessment. Regression models compared observed rates in April 2020 and between March and December 2020 with trend-adjusted expected rates derived from 10-year historical data. Results: In April 2020, in English practices, rates of performing health checks were reduced by 76%–88% when compared with 10-year historical trends, with older people from deprived areas experiencing the greatest reductions. Between May and December 2020, the reduced rates recovered gradually but overall remained 28%–47% lower, with similar findings in other UK nations. Extrapolated to the UK population, there were ~7.4 million fewer care processes undertaken March–December 2020. In England, rates for new medication fell during April with reductions varying from 10% (95% CI: 4% to 16%) for antiplatelet agents to 60% (95% CI: 58% to 62%) for antidiabetic medications. Overall, between March and December 2020, the rate of prescribing new diabetes medications fell by 19% (95% CI: 15% to 22%) and new antihypertensive medication prescribing fell by 22% (95% CI: 18% to 26%), but prescribing of new lipid-lowering or antiplatelet therapy was unchanged. Similar trends were observed across the UK, except for a reduction in new lipid-lowering therapy prescribing in the other UK nations (reduction: 16% (95% CI: 10% to 21%)). Extrapolated to the UK population, between March and December 2020, there were ~31 800 fewer people with T2D prescribed a new type of diabetes medication and ~14 600 fewer prescribed a new type of antihypertensive medication. Conclusions: Over the coming months, healthcare services will need to manage this backlog of testing and prescribing. We recommend effective communications to ensure patient engagement with diabetes services, monitoring and opportunities for prescribing, and when appropriate use of home monitoring, remote consultations and other innovations in care.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmjqs-2021-013613

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Research works printed but not linked: 26

  1. 10.1371/journal.pone.0132883 · DOI
  2. 10.1186/1472-6963-10-169 · DOI
  3. 10.1136/bmjdrc-2016-000291 · DOI
  4. 10.1136/bmjqs-2012-001033 · DOI
  5. 10.1136/bmj.m3348 · DOI
  6. Holman, 2020, Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study, Lancet Diabetes Endocrinol, 8, 823, 10.1016/S2213-8587(20)30271-0 · DOI · Paper page
  7. Barron, 2020, Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study, Lancet Diabetes Endocrinol, 8, 813, 10.1016/S2213-8587(20)30272-2 · DOI · Paper page
  8. 10.1016/j.pcd.2010.02.003 · DOI
  9. Carr, 2021, Impact of COVID-19 on diagnoses, monitoring, and mortality in people with type 2 diabetes in the UK, Lancet Diabetes Endocrinol, 9, 413, 10.1016/S2213-8587(21)00116-9 · DOI
  10. 10.1371/journal.pone.0251143 · DOI
  11. 10.2337/dc20-1176 · DOI
  12. 10.2337/dc20-0954 · DOI
  13. 10.2337/dc20-1127 · DOI
  14. Cusinato, 2021, Anxiety, depression, and glycemic control during Covid-19 pandemic in youths with type 1 diabetes, J Pediatr Endocrinol Metab, 10.1515/jpem-2021-0153 · DOI
  15. 10.1016/j.appet.2020.104853 · DOI · Paper page
  16. 10.1002/osp4.442 · DOI
  17. 10.1016/j.pcd.2021.01.003 · DOI
  18. 10.1007/s12020-021-02739-5 · DOI
  19. 10.1016/j.diabres.2021.108840 · DOI
  20. Rastogi, 2020, Improved glycemic control amongst people with long-standing diabetes during COVID-19 lockdown: a prospective, observational, nested cohort study, Int J Diabetes Dev Ctries, 476, 10.1007/s13410-020-00880-x · DOI
  21. Ruissen, 2021, Increased stress, weight gain and less exercise in relation to glycemic control in people with type 1 and type 2 diabetes during the COVID-19 pandemic, BMJ Open Diabetes Res Care, 9, 10.1136/bmjdrc-2020-002035 · DOI · Paper page
  22. 10.1016/j.diabres.2020.108285 · DOI
  23. 10.1530/eje-20-0377 · DOI
  24. 10.1016/S2468-2667(20)30201-2 · DOI · Paper page
  25. 10.1016/S2468-2667(20)30288-7 · DOI · Paper page
  26. Mansfield, 2021, Indirect acute effects of the COVID-19 pandemic on physical and mental health in the UK: a population-based study, Lancet Digit Health, 3, e217, 10.1016/S2589-7500(21)00017-0 · DOI · Paper page

Cited by

See all 222

Metadata

Authors
Carr, M. J., Wright, A. K., Leelarathna, L., Thabit, H., Milne, N., Kanumilli, N., Ashcroft, D. M., & Rutter, M. K.
Venue
BMJ Quality & Safety
Publisher
BMJ
Published
2021-10-12
Volume
31
Issue
7
Pages
503-514
ISSN
  • 1475-3898 (ISSN-L)
  • 2044-5415
  • 2044-5423
OpenAlex
W3206592938
Cited by
222
References
5
FWCI
17.28
Type
journal article
Language
en
Open access
hybrid
Funders
National Institute for Health Research (NIHR) Greater Manchester Patient Safety Translational Research Centre (PSTRC-2016-003)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Impact of COVID-19 restrictions on diabetes health checks and prescribing for people with type 2 diabetes: a UK-wide cohort study involving 618 161 people in primary care. https://app.cochat.ai/papers/10.1136/bmjqs-2021-013613
The paper
Carr, M. J., Wright, A. K., Leelarathna, L., Thabit, H., Milne, N., Kanumilli, N., Ashcroft, D. M., & Rutter, M. K. (2022). Impact of COVID-19 restrictions on diabetes health checks and prescribing for people with type 2 diabetes: a UK-wide cohort study involving 618 161 people in primary care. BMJ Quality & Safety. https://doi.org/10.1136/bmjqs-2021-013613

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.